Junjie Cen

946 total citations
31 papers, 647 citations indexed

About

Junjie Cen is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Junjie Cen has authored 31 papers receiving a total of 647 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 13 papers in Cancer Research and 11 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Junjie Cen's work include Circular RNAs in diseases (8 papers), Cancer-related molecular mechanisms research (8 papers) and MicroRNA in disease regulation (7 papers). Junjie Cen is often cited by papers focused on Circular RNAs in diseases (8 papers), Cancer-related molecular mechanisms research (8 papers) and MicroRNA in disease regulation (7 papers). Junjie Cen collaborates with scholars based in China, United States and Taiwan. Junjie Cen's co-authors include Junhang Luo, Yanping Liang, Yihui Pan, Jiaxing Zhang, Yong Huang, Guannan Shu, Jinhuan Wei, Mi Zhou, Zhenhua Chen and Yong Fang and has published in prestigious journals such as Cancer Research, Oncogene and Molecular Cancer.

In The Last Decade

Junjie Cen

28 papers receiving 641 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Junjie Cen China 15 470 341 136 94 55 31 647
Bosen You China 16 481 1.0× 302 0.9× 190 1.4× 99 1.1× 80 1.5× 30 688
Yuanda Cheng China 15 432 0.9× 330 1.0× 105 0.8× 83 0.9× 47 0.9× 37 594
Yilin Hu China 13 555 1.2× 472 1.4× 78 0.6× 84 0.9× 60 1.1× 32 710
Xiaoying Xue China 13 317 0.7× 180 0.5× 99 0.7× 100 1.1× 62 1.1× 57 495
Jingdong He China 16 650 1.4× 546 1.6× 90 0.7× 140 1.5× 75 1.4× 29 829
Yu Yin China 13 329 0.7× 254 0.7× 94 0.7× 106 1.1× 35 0.6× 30 525
Jianfeng Sang China 12 459 1.0× 368 1.1× 62 0.5× 130 1.4× 97 1.8× 42 692
Zhenghui Guo China 13 359 0.8× 239 0.7× 128 0.9× 101 1.1× 46 0.8× 34 661
Zewei He China 7 383 0.8× 342 1.0× 120 0.9× 60 0.6× 24 0.4× 7 549

Countries citing papers authored by Junjie Cen

Since Specialization
Citations

This map shows the geographic impact of Junjie Cen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junjie Cen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junjie Cen more than expected).

Fields of papers citing papers by Junjie Cen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junjie Cen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junjie Cen. The network helps show where Junjie Cen may publish in the future.

Co-authorship network of co-authors of Junjie Cen

This figure shows the co-authorship network connecting the top 25 collaborators of Junjie Cen. A scholar is included among the top collaborators of Junjie Cen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junjie Cen. Junjie Cen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Yunfei, Taowei Yang, Qihao Li, et al.. (2025). circASAP1 induces renal clear cell carcinoma ferroptosis by binding to HNRNPC and thereby regulating GPX4. Molecular Cancer. 24(1). 1–1. 11 indexed citations
2.
Cen, Junjie, X. D. Shi, Jinlong Chen, et al.. (2025). N6-methyladenosine-mediated upregulation of MANF promotes ER stress resistance in renal cell carcinoma. Cell Death and Disease. 16(1). 486–486.
3.
Luo, Jiabao, Minyu Chen, Jinwei Chen, et al.. (2024). Machine learning-derived natural killer cell signature predicts prognosis and therapeutic response in clear cell renal cell carcinoma. Translational Oncology. 51. 102180–102180. 3 indexed citations
4.
Shu, Guannan, Xuanxuan Lu, Yihui Pan, et al.. (2023). Exosomal circSPIRE1 mediates glycosylation of E-cadherin to suppress metastasis of renal cell carcinoma. Oncogene. 42(22). 1802–1820. 32 indexed citations
5.
Cen, Junjie, Yanping Liang, Zihao Feng, et al.. (2023). Hsa_circ_0057105 modulates a balance of epithelial‐mesenchymal transition and ferroptosis vulnerability in renal cell carcinoma. Clinical and Translational Medicine. 13(8). e1339–e1339. 13 indexed citations
6.
Huang, Yong, Junjie Cen, Yiming Tang, et al.. (2023). Robot-assisted partial nephrectomy for large complex renal cancer: step-by-step segmental artery unclamping. International braz j urol. 49(3). 393–394. 3 indexed citations
7.
Gui, Chengpeng, Jinhuan Wei, Chengqiang Mo, et al.. (2023). Therapeutic implications for localized prostate cancer by multiomics analyses of the ageing microenvironment landscape. International Journal of Biological Sciences. 19(12). 3951–3969. 5 indexed citations
8.
Zheng, Zhousan, Mi Zhou, Yunfei Wang, et al.. (2023). EGCG‐LYS Fibrils‐Mediated CircMAP2K2 Silencing Decreases the Proliferation and Metastasis Ability of Gastric Cancer Cells in Vitro and in Vivo. Advanced Science. 10(32). e2304075–e2304075. 13 indexed citations
9.
Xiong, Hui, Ni Kong, Jiongjie Jing, et al.. (2023). Cytotoxic CD161−CD8+ TEMRA cells contribute to the pathogenesis of systemic lupus erythematosus. EBioMedicine. 90. 104507–104507. 15 indexed citations
10.
Pan, Yihui, Xuanxuan Lu, Guannan Shu, et al.. (2022). Extracellular Vesicle-Mediated Transfer of LncRNA IGFL2-AS1 Confers Sunitinib Resistance in Renal Cell Carcinoma. Cancer Research. 83(1). 103–116. 58 indexed citations
13.
Feng, Zihao, Yanping Liang, Junjie Cen, et al.. (2022). m6A-immune-related lncRNA prognostic signature for predicting immune landscape and prognosis of bladder cancer. Journal of Translational Medicine. 20(1). 492–492. 47 indexed citations
14.
Liang, Yanping, Junjie Cen, Yong Huang, et al.. (2022). CircNTNG1 inhibits renal cell carcinoma progression via HOXA5-mediated epigenetic silencing of Slug. Molecular Cancer. 21(1). 224–224. 16 indexed citations
15.
Cen, Junjie, Yanping Liang, Yong Huang, et al.. (2021). Circular RNA circSDHC serves as a sponge for miR-127-3p to promote the proliferation and metastasis of renal cell carcinoma via the CDKN3/E2F1 axis. Molecular Cancer. 20(1). 19–19. 85 indexed citations
16.
Lü, Jun, Junjie Cen, Wenwei Wang, et al.. (2021). Localization of external urethral orifice in coronary sulcus during urethroplasty in case of severe hypospadias accompanied by prostatic utricle cyst. BMC Urology. 21(1). 149–149. 1 indexed citations
17.
Tan, Lei, Yiming Tang, Hongbo Li, et al.. (2021). N6-Methyladenosine Modification of LncRNA DUXAP9 Promotes Renal Cancer Cells Proliferation and Motility by Activating the PI3K/AKT Signaling Pathway. Frontiers in Oncology. 11. 641833–641833. 26 indexed citations
19.
Feng, Zihao, Yong Fang, Jun Lü, et al.. (2017). RIN1 promotes renal cell carcinoma malignancy by activating EGFR signaling through Rab25. Cancer Science. 108(8). 1620–1627. 19 indexed citations
20.
Chen, Zhenhua, Jiaxing Zhang, Zhiling Zhang, et al.. (2017). The putative tumor suppressor microRNA-30a-5p modulates clear cell renal cell carcinoma aggressiveness through repression of ZEB2. Cell Death and Disease. 8(6). e2859–e2859. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026